Zenon Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
as on 21-05-2024
- Paid Up Capital ₹ 1.25 Cr
as on 21-05-2024
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.99 Cr
as on 21-05-2024
- Satisfied Charges ₹ 3.96 Cr
as on 21-05-2024
- Revenue 1191.33%
(FY 2022)
- Profit 55.82%
(FY 2022)
- Ebitda 34.29%
(FY 2022)
- Net Worth -71.69%
(FY 2022)
- Total Assets 33.47%
(FY 2022)
About Zenon Lifesciences
The Corporate was formerly known as Manimed Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.25 Cr.
The company currently has active open charges totaling ₹4.99 Cr. The company has closed loans amounting to ₹3.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Tulsyan, Chaitanya Tulsyan, Kanaiya Bhalara, and Three other members serve as directors at the Company.
- CIN/LLPIN
U36912GJ2015PTC082749
- Company No.
082749
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Zenon Lifesciences?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Tulsyan  | Director | 30-Sep-2019 | Current |
| Sanjay Tulsyan | Director | 30-Sep-2019 | Current |
| Chaitanya Tulsyan | Director | Current | |
| Kanaiya Bhalara | Director | 20-Oct-2016 | Current |
| Milan Viradiya | Director | 30-Mar-2015 | Current |
| Arun Tulsiyan | Director | Current |
Financial Performance of Zenon Lifesciences.
Zenon Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1191.33% increase. The company also saw a substantial improvement in profitability, with a 55.82% increase in profit. The company's net worth observed a substantial decline by a decrease of 71.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenon Lifesciences?
Unlock access to Zenon Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Orion Biotech Private LimitedActive 20 years 8 monthsSanjay Tulsyan and Abhishek Tulsyan are mutual person
Aronex Life Sciences Private LimitedActive 21 years 2 monthsSanjay Tulsyan and Chaitanya Tulsyan are mutual person
Zenon Healthcare LimitedActive 22 years 5 monthsAbhishek Tulsyan and Arun Tulsiyan are mutual person
Astrica Biomedics Private LimitedActive 11 years 5 monthsSanjay Tulsyan and Abhishek Tulsyan are mutual person
- Tisenta Medicare India LlpActive 5 years 7 months
Sanjay Tulsyan and Abhishek Tulsyan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Feb 2023 | ₹3.90 M | Open |
Others Creation Date: 28 Feb 2023 | ₹3.00 Cr | Open |
Others Creation Date: 28 Feb 2023 | ₹1.60 Cr | Open |
How Many Employees Work at Zenon Lifesciences?
Zenon Lifesciences has a workforce of 37 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenon Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenon Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
